adverse
-
PPD to Evaluate US FDA Public Health Surveillance System
PPD has been awarded a contract by the US Food and Drug Administration (FDA) to evaluate the agency's Center for Drug Evaluation and Research (CDER) post-market spontaneous adverse event surveillance system. The company will conduct an evaluation…
adverse | 03 December 2009
-
Pharmacovigilance in Emerging Markets
National regulators in Asia Pacific are intensifying their efforts to manage the risk of adverse drug reactions.
adverse | 01 September 2009
